Pacific Biosciences Of California (PACB) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -1.90% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 49.83% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 70.10% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -3.89% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -7.16% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 33.16% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -17.17% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 32.55% |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 13.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.83% |
| Mar 31, 2026 | 54.87% |
| Dec 31, 2025 | 21.92% |
| Sep 30, 2025 | 21.23% |
| Jun 30, 2025 | 16.28% |
| Mar 31, 2025 | -73.60% |
| Dec 31, 2024 | 26.81% |
| Jun 30, 2024 | -61.48% |
| Mar 31, 2024 | -30.10% |
| Dec 31, 2023 | -45.87% |
| Sep 30, 2023 | -48.46% |
| Jun 30, 2023 | -43.72% |
| Mar 31, 2023 | -38.71% |
| Dec 31, 2022 | -65.56% |
| Sep 30, 2022 | -38.81% |
| Jun 30, 2022 | -41.83% |
| Mar 31, 2022 | -38.38% |
| Dec 31, 2021 | -29.68% |
| Jun 30, 2021 | -22.59% |
| Mar 31, 2021 | -13.11% |